Dabur Pharma gained 4.78 per cent to Rs 55.65 after the company received approval to sell the irinotecan hydrochloride injection in Italy and Denmark. Irinotecan hydrochloride injection is the generic version of Pfizer's Camptosar. On BSE, 38,323 shares were traded on the counter. The scrip had an average daily volume of 1.30 lakh shares in the past one quarter. The stock hit a high of Rs 58 and a low of Rs 53.50 during the day. The company successfully launched the generic version of the drug in the US recently, being among the first of a handful of companies to do so. It also has approval for the drug in the UK.